CN101810636B - 山药多糖在制备治疗肥胖症的药物的用途 - Google Patents
山药多糖在制备治疗肥胖症的药物的用途 Download PDFInfo
- Publication number
- CN101810636B CN101810636B CN2010101715573A CN201010171557A CN101810636B CN 101810636 B CN101810636 B CN 101810636B CN 2010101715573 A CN2010101715573 A CN 2010101715573A CN 201010171557 A CN201010171557 A CN 201010171557A CN 101810636 B CN101810636 B CN 101810636B
- Authority
- CN
- China
- Prior art keywords
- chinese yam
- yam polysaccharide
- polysaccharide
- precipitate
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 76
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 70
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 70
- 235000002722 Dioscorea batatas Nutrition 0.000 title claims abstract description 65
- 235000006536 Dioscorea esculenta Nutrition 0.000 title claims abstract description 65
- 240000001811 Dioscorea oppositifolia Species 0.000 title claims abstract description 65
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 title claims abstract description 65
- 208000008589 Obesity Diseases 0.000 title claims abstract description 27
- 235000020824 obesity Nutrition 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 230000000694 effects Effects 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000003826 tablet Substances 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 6
- 239000006188 syrup Substances 0.000 claims abstract description 5
- 235000020357 syrup Nutrition 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 239000002244 precipitate Substances 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000008021 deposition Effects 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 102000011759 adducin Human genes 0.000 claims description 5
- 108010076723 adducin Proteins 0.000 claims description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 229960004756 ethanol Drugs 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000000247 postprecipitation Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 4
- 239000003937 drug carrier Substances 0.000 abstract description 4
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- 240000008415 Lactuca sativa Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 235000012045 salad Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 150000004804 polysaccharides Polymers 0.000 description 6
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 241000234272 Dioscoreaceae Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000003579 anti-obesity Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 235000021590 normal diet Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241001529246 Platymiscium Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229960001877 fenfluramine hydrochloride Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000000892 gravimetry Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(mg/kg) | 动物数(N) | 第一周 | 第五周 |
生理盐水组 | ------ | 10 | 368.6±25.8 | 429.3±16.8 |
肥胖模型组 | ------ | 10 | 456.7±10.9 | 494.6±8.8 |
芬氟拉明组 | 6.25 | 10 | 371.0±18.3 | 365.7±12.5 |
山药粗多糖组(小) | 370 | 15 | 422.3±23.8 | 405±28.4 |
山药粗多糖组(大) | 740 | 15 | 464.3±10.9 | 437.5±18.0 |
山药纯多糖组(小) | 167 | 15 | 432.7±19.6 | 409.3±9.7 |
山药纯多糖组(大) | 330 | 15 | 457.3±23.8 | 389±7.3 |
组别 | 剂量(mg/kg) | 动物数(N) | 脂肪湿重 |
生理盐水组 | ------ | 10 | 6.47±1.83 |
肥胖模型组 | ------ | 10 | 11.86±2.82 |
芬氟拉明组 | 6.25 | 10 | 6.96±0.83 |
山药粗多糖组(小) | 370 | 15 | 5.53±0.61 |
山药粗多糖组(大) | 740 | 15 | 5.56±0.77 |
山药纯多糖组(小) | 167 | 15 | 6.09±1.07 |
山药纯多糖组(大) | 330 | 15 | 6.00±1.20 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101715573A CN101810636B (zh) | 2010-05-13 | 2010-05-13 | 山药多糖在制备治疗肥胖症的药物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101715573A CN101810636B (zh) | 2010-05-13 | 2010-05-13 | 山药多糖在制备治疗肥胖症的药物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101810636A CN101810636A (zh) | 2010-08-25 |
CN101810636B true CN101810636B (zh) | 2012-01-04 |
Family
ID=42618097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101715573A Expired - Fee Related CN101810636B (zh) | 2010-05-13 | 2010-05-13 | 山药多糖在制备治疗肥胖症的药物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101810636B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102746417A (zh) * | 2012-07-30 | 2012-10-24 | 焦作市易生元酒业股份有限公司 | 一种采用酶法提取怀山药多糖的提取工艺 |
CN102920991B (zh) * | 2012-12-05 | 2014-05-07 | 多力坤·马木特 | 山药多糖和山药蛋白质的组合物的用途 |
CN106923340A (zh) * | 2017-03-28 | 2017-07-07 | 许昌学院 | 一种山药多糖口服液及其制备方法 |
CN109480199B (zh) * | 2018-12-30 | 2022-05-27 | 北京蓉山食品有限公司 | 发酵型红油豆瓣酱及其制作方法 |
CN113101333A (zh) * | 2021-04-27 | 2021-07-13 | 河南理工大学 | 怀山药提取物作为唯一有效成分在制备预防和治疗肥胖产品中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129710A (zh) * | 2007-09-11 | 2008-02-27 | 多力坤·马木特 | 一种治疗代谢综合征的天然药物及其制备方法 |
-
2010
- 2010-05-13 CN CN2010101715573A patent/CN101810636B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129710A (zh) * | 2007-09-11 | 2008-02-27 | 多力坤·马木特 | 一种治疗代谢综合征的天然药物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
吴国欣,陈密玉等.《南瓜多糖的提取与分离工艺的优化》.《海峡药学》.2003,第15卷(第4期),第52-55页. * |
顾林,姜军.《山药多糖的分离纯化及组成研究》.《食品科学》.2007,第28卷(第9期),第158-160页. * |
黄泰康.山药.《常用中药成分与药理手册(上册)》.中国医药科技出版社,1994,第389-390页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101810636A (zh) | 2010-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100998650A (zh) | 肉桂在治疗糖尿病上的用途及产品和其制备方法 | |
CN102727586A (zh) | 预防和治疗糖尿病的组合物 | |
CN101810636B (zh) | 山药多糖在制备治疗肥胖症的药物的用途 | |
CN108578544A (zh) | 一种具有降糖作用的中药组合物及其制备方法与应用 | |
CN105338993A (zh) | 含复合提取物的用于预防、改善或治疗大肠炎的组合物 | |
RU2431494C1 (ru) | Антипаразитарный сбор | |
WO2003045409A1 (fr) | Composition pharmaceutique produite a partir de medecine traditionnelle chinoise et son procede de production | |
CN111166820B (zh) | 一种含佛手的中药组合物及制剂和用途 | |
CN1329049C (zh) | 降血糖、降血压的药物 | |
CN102319289A (zh) | 肉桂多酚等组成的降血糖中药组合物及其制备方法 | |
EP1369123A1 (en) | A health-care product comprising lotus rhizome and process for its preparation | |
CN103168994A (zh) | 一种减肥保健组合物及其制备方法 | |
CN1985917B (zh) | 用于降血糖、降血脂、控制糖尿病并发症的组合物 | |
CN118434431A (zh) | 一种中药组合物及其制备方法与应用 | |
KR101732483B1 (ko) | 연교 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물 | |
CN100579564C (zh) | 一种治疗痛风的药物及其制备方法 | |
JP2004352626A (ja) | 植物由来成分を含有する抗コレステロール剤 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
KR100685472B1 (ko) | 식초 가공 인삼제제를 이용한 제2형 당뇨병과대사증후군의 예방 및 치료용 조성물 | |
CN101120969A (zh) | 一种治疗糖尿病及其并发症的药物及其制备方法 | |
KR101113593B1 (ko) | 홍삼, 천마 및 하수오 혼합 추출물을 유효 성분으로 하는 발기부전 질환의 예방과 치료를 위한 조성물 | |
CN1795901B (zh) | 一种清热解毒、利湿退黄的药物 | |
WO2018188548A1 (zh) | 一种具有降血糖作用的中药组合物 | |
KR20170103602A (ko) | 진피를 포함한 생약 조합 추출물을 유효성분으로 함유하는 변비 예방 및 치료용 조성물 | |
CN114588193B (zh) | 一种含山竹活性物的组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KASHI AIWEIMATE UYGUR PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: MAMUTE DUOLIKUN Effective date: 20140606 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 830002 URUMQI, XINJIANG UYGUR AUTONOMOUS REGION TO: 844000 KASHGAR, XINJIANG UYGUR AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140606 Address after: 844000, Yingbin Road, the Xinjiang Uygur Autonomous Region, Kashi, No. 288 Patentee after: Kashi alamart Uygur Pharmaceutical Co.,Ltd. Address before: 830002 No. 496 Xinhua South Road, the Xinjiang Uygur Autonomous Region, Urumqi Patentee before: Duolikun.Mamute |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120104 Termination date: 20190513 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
RR01 | Reinstatement of patent right |
Former decision: termination of patent right due to unpaid annual fee Former decision publication date: 20200501 |
|
RR01 | Reinstatement of patent right | ||
RR01 | Reinstatement of patent right |
Former decision: Termination of patent right without annual fee Former decision publication date: 20200501 |
|
RR01 | Reinstatement of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120104 |